Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.24.3
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Beginning balance, value at Dec. 31, 2022 $ 32,990 $ 0 $ 425,196 $ (392,080) $ (126)
Beginning balance, shares at Dec. 31, 2022   4,171,297      
Issuance of common stock, net of issuance costs 109   109    
Issuance of common stock, net of issuance costs, shares   14,106      
Issuance of common stock upon conversion of K2 Loan and Security Agreement, Shares   194,444      
Issuance of common stock upon conversion of K2 Loan and Security Agreement, Value 875   875    
Issuance of common stock upon exercise of stock options 130   130    
Issuance of common stock upon exercise of stock options, shares   43,836      
Stock-based compensation expense 2,671   2,671    
Change in unrealized gain (loss) on marketable debt securities 119       119
Net loss (36,582)     (36,582)  
Ending balance, value at Sep. 30, 2023 312 $ 0 428,981 (428,662) (7)
Ending balance, shares at Sep. 30, 2023   4,423,683      
Beginning balance, value at Jun. 30, 2023 9,521 $ 0 428,153 (418,609) (23)
Beginning balance, shares at Jun. 30, 2023   4,422,741      
Issuance of common stock, net of issuance costs 7   7    
Issuance of common stock, net of issuance costs, shares   942      
Stock-based compensation expense 821   821    
Change in unrealized gain (loss) on marketable debt securities 16       16
Net loss (10,053)     (10,053)  
Ending balance, value at Sep. 30, 2023 312 $ 0 428,981 (428,662) (7)
Ending balance, shares at Sep. 30, 2023   4,423,683      
Beginning balance, value at Dec. 31, 2023 (6,905) $ 0 429,780 (436,684) (1)
Beginning balance, shares at Dec. 31, 2023   4,423,683      
Issuance of common stock, net of issuance costs 180,237 $ 1 180,236    
Issuance of common stock, net of issuance costs, shares   7,462,916      
Issuance of common stock upon cashless exercise of warrants, shares   6,087      
Issuance of common stock upon conversion of K2 Loan and Security Agreement, Shares   142,857      
Issuance of common stock upon conversion of K2 Loan and Security Agreement, Value 1,125   1,125    
Issuance of common stock upon exercise of stock options $ 1,999   1,999    
Issuance of common stock upon exercise of stock options, shares 136,664 136,664      
Issuance of common stock upon vesting of restricted stock, shares   7,275      
Stock-based compensation expense $ 4,513   4,513    
Change in unrealized gain (loss) on marketable debt securities 208       208
Net loss (30,679)     (30,679)  
Ending balance, value at Sep. 30, 2024 150,498 $ 1 617,653 (467,363) 207
Ending balance, shares at Sep. 30, 2024   12,179,482      
Beginning balance, value at Jun. 30, 2024 125,543 $ 1 579,510 (453,580) (388)
Beginning balance, shares at Jun. 30, 2024   11,498,917      
Issuance of common stock, net of issuance costs 35,842   35,842    
Issuance of common stock, net of issuance costs, shares   668,379      
Issuance of common stock upon cashless exercise of warrants, shares   6,087      
Issuance of common stock upon exercise of stock options 58   58    
Issuance of common stock upon exercise of stock options, shares   2,588      
Issuance of common stock upon vesting of restricted stock, shares   3,511      
Stock-based compensation expense 2,243   2,243    
Change in unrealized gain (loss) on marketable debt securities 595       595
Net loss (13,783)     (13,783)  
Ending balance, value at Sep. 30, 2024 $ 150,498 $ 1 $ 617,653 $ (467,363) $ 207
Ending balance, shares at Sep. 30, 2024   12,179,482